Evidence map›Paper›PMID 40108927›Full record

ArticleCurrent pharmaceutical biotechnology2026

Salma Batool, Izzah Shahid, Moaiza Iftikhar, Burhan Haider, Farah Deeba, Rahman Shah Zaib Saleem

Abstract read
PubMed Publisher
In one paragraph

Article in Current pharmaceutical biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Salma BatoolDepartment of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab Lahore, 54782, Pakistan.ORCID 0000-0003-2394-4701
Izzah ShahidInstitute of Multidisciplinary Research in Applied Biology (IMAB), Public University of Navarre (UPNA), Campus Arrosadia, Pamplona, 31006, Spain.ORCID 0000-0001-7046-807X
Moaiza IftikharDepartment of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab Lahore, 54782, Pakistan.
Burhan HaiderDepartment of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab Lahore, 54782, Pakistan.
Farah DeebaDepartment of Biochemistry and Biotechnology, The Women University Multan, Pakistan.
Rahman Shah Zaib SaleemDepartment of Chemistry and Chemical Engineering, SBA School of Science and Engineering (SBASSE), Lahore University of Management Sciences (LUMS), Lahore, 54792, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRapid spread of antimicrobial drug resistance is alarming and demands a sustainable solution. Green synthesis of silver nanoparticles can pave the way for the development of adjuvants that can help overcome bacterial drug resistance.

methodsIn the current study, green synthesis of silver nanoparticles utilizing pea (Pisum sativum) peels and their evaluation against multidrug-resistant (MDR) bacterial pathogens has been proposed. Pea peels were extracted and analyzed for antioxidant potential by non-enzymatic DPPH assay. The extract was used to prepare silver nanoparticles (gAgNPs) characterized using UV-VIS spectroscopy, SEM, FTIR, and zeta sizer, and evaluated for antibacterial activity.

resultsThe SEM showed that the gAgNPs were spherical with a size of 59.24 nm ± 0.3, and the zeta sizer gave a PDI of 0.2. As adjuvants, these gAgNPs in combination with vancomycin showed a superior antibacterial activity against vancomycin-resistant

conclusionThis study suggests these gAgNPs could be a good lead to work as adjuvants with vancomycin against vancomycin-resistant Gram-positive and Gram-negative clinical bacteria and thus warrants further studies.

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialMetal NanoparticlesPisum sativumPlant ExtractsSilverAntioxidantsGreen Chemistry TechnologyMicrobial Sensitivity TestsAnti-Bacterial AgentsAntioxidantsPlant ExtractsSilverantibiotic resistanceDPPH assaygreen synthesisMDRPisum sativumsilver nanoparticles

Identifiers

PMID40108927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.